digital therapeutics

News

Pear Tx files for bankruptcy, will seek to sell assets

Boston-based Pear Therapeutics, one of the first digital therapeutics companies to secure FDA clearance and forge pharma partnerships, is bowing out.

News

Poll finds just one fifth of doctors have prescribed a DTx

A large, international survey of thousands of doctors has revealed that a majority are still not confident enough to prescribe

News

Future Health report: Expert opinion on digital therapeutics

Healthware Group has released the expert opinion report, ‘Digital therapeutics to enhance the care pathways for depression across the national health service: expert propo

News

Digital health firm Pear considers future as cash dwindles

Company looks at possible sale, merger or licensing deal after making big layoffs last year.

Digital

DTx and the case for fit-for-purpose evidentiary standard

DTx deliver evidence-based therapeutic interventions driven by high-quality software programs

Digital

The connected care horizon in 2023

Some connected care trends expected include digital therapeutics & remote patient monitoring.

Pear Tx files for bankruptcy, will seek to sell assets

Poll finds just one fifth of doctors have prescribed a DTx

Future Health report: Expert opinion on digital therapeutics

Digital health firm Pear considers future as cash dwindles

DTx and the case for fit-for-purpose evidentiary standard

The connected care horizon in 2023

Remepy's hybrid Parkinson's therapy poised for phase 3

Discover a new era of healthcare panel engagement: Grounded ...

digital therapeutics

Editor's Picks